Universal Health Services (UHS) Earnings Date & Reports

Key Takeaways

• Net revenue rose 5.3% year over year to $4.73 billion, roughly in line with analyst consensus of about $4.71 billion.
• Adjusted earnings per share (EPS, a measure of profit allocated to each share) came in at $5.22, edging past the consensus estimate of approximately $5.15 but down from $5.69 a year earlier.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $624.6 million fell short of the roughly $634.9 million analysts expected.
• Adjusted operating margin declined to 10.2%, down 1.4 percentage points from the prior-year quarter, while same-store sales advanced 4.7%.
• Universal Health Services reported third-quarter net income of $308.7 million and repurchased 1.35 million shares for about $242.1 million during the period.
• For more on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for the UHS ticker.
• Explore Trending AI Robots to see AI-driven trading strategies currently capturing investor attention.

Earnings Context and Why It Matters

Universal Health Services is one of the nation's largest hospital and healthcare providers, operating both acute care and behavioral health facilities. Its quarterly results serve as a closely watched barometer for labor costs, patient volumes, and reimbursement trends across the broader hospital industry. The third quarter arrived after a challenging second quarter in which UHS beat on revenue but trimmed full-year EPS guidance, and in which two behavioral health facilities lost their licenses. With investors focused on whether margins in the behavioral health segment were stabilizing, this report was a key test of the company's ability to manage elevated operating expenses while sustaining revenue growth.

Reported Results

Universal Health Services reported third-quarter 2026 net revenue of $4.73 billion, up 5.3% from the same period last year and essentially in line with the consensus estimate of about $4.71 billion. Same-store sales increased 4.7% year over year, a notable acceleration from the 2% growth recorded in the year-ago quarter.

Adjusted EPS came in at $5.22, slightly above the consensus estimate of roughly $5.15 but below the $5.69 reported a year earlier. The company posted third-quarter net income of $308.7 million. Adjusted EBITDA was $624.6 million, missing the consensus estimate of approximately $634.9 million and reflecting a 13.2% margin.

Profitability remained under pressure. The adjusted operating margin declined to 10.2%, down 1.4 percentage points year over year, while the reported operating margin fell to 9.6% from 11.6% a year ago. Results included a net favorable pre-tax impact of about $21 million from increases in Medicaid supplemental payment programs, partially offset by a $26 million unfavorable pre-tax charge tied to higher reserves for self-insured professional and general liability claims.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Universal Health Services, the AI Screener offers a structured way to surface new opportunities across the healthcare sector.

Market Reaction and Investor Sentiment

Investor reaction to the report was relatively muted. Shares closed at roughly $177.32 on the release day and were little changed in initial after-hours trading, reflecting a mixed quarter in which a modest EPS beat was offset by an EBITDA miss and continued margin compression. The stock had gained about 5% over the prior three months but remained down roughly 19% over the trailing 12 months, underscoring lingering caution around the hospital operator's cost pressures and the behavioral health segment's recovery.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be watching several themes closely. Management previously guided to full-year 2026 net revenue between $18.417 billion and $18.789 billion, adjusted EBITDA net of noncontrolling interests (NCI, the portion of earnings owned by outside investors in consolidated subsidiaries) between $2.641 billion and $2.789 billion, and EPS between $22.64 and $24.52.

A central focus will be whether the behavioral health segment can stabilize its margins following the recent licensing setbacks and the ongoing Cumberland litigation. Labor costs, specifically salaries, wages, and benefits, remain a key swing factor for hospital profitability, and any sustained easing of staffing expenses would support margin recovery.

Investors should also monitor the potential impact of changes to Medicaid reimbursement, which the company flagged as a possible influence on annual results. Finally, capital-allocation activity, including the ongoing share repurchase program with roughly $735.4 million remaining in authorization, may continue to shape per-share results in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations